Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2005-09-19
2010-11-09
Goldberg, Jeanine A (Department: 1634)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091100, C435S091200, C536S023100, C536S024300
Reexamination Certificate
active
07829281
ABSTRACT:
Methods and constructs are provided that are predictive of a subject's susceptibility to developing a metabolic disorder, such as obesity. The disclosed naturally-occurring SNPs located upstream of the NPY2R gene can be used as targets for the design of diagnostic reagents and the development of therapeutic agents, as well as for disease association and linkage analysis. In particular, the SNPs of the present invention are useful for identifying an individual who is at an increased or decreased risk of developing metabolic disorders, such as obesity and diabetes, and for early detection of the disease, for providing clinically important information for the prevention and/or treatment of metabolic disorder, and for screening and selecting therapeutic agents. The SNPs disclosed herein are also useful for human identification applications. Methods, assays, kits, and reagents for detecting the presence of these polymorphisms and their encoded products are provided.
REFERENCES:
patent: 2003/0092019 (2003-05-01), Meyer et al.
patent: 03/097683 (2003-11-01), None
Hung et al. (Diabètes, vol. 53, pp. 2461-2466, Sep. 2004).
Ma et al. (Diabetes, vol. 54, pp. 1598-1602, May 2005).
Torekov et al. (Diebetologia, vol. 49, pp. 2653-2658, 2006).
Siddiq (Diabetologia et al., vol. 50, pp. 574-584, 2007).
Lucentini (The Scientist; 2004, vol. 24, p. 20).
Hirschhorn et al. (Genetics in Medicine. vol. 4, No. 2, pp. 45-61, Mar. 2002).
Ioannidis (Nature Genetics, vol. 29, pp. 306-309, Nov. 2001).
Engert et al., “5′ Flanking Variants Of Resistin Are Associated With Obesity”,Diabetes, vol. 51, pp. 1629-1634, 2002.
Hirschhorn et al., “Editorial: Once and Again—Issues Surrounding Replication In Genetic Association Studies”,The Journal of Clinical Endocrinology&Metabolism, vol. 87, pp. 4438-4441, 2002.
Lohmueller et al., “Meta-Analysis Of Genetic Association Studies Supports A Contribution Of Common Variants To Susceptibility to Common Disease”,Nature Genetics, vol. 33, pp. 177-182, 2003.
Matsumoto et al., “Inactivation of a Novel Neuropeptide Y/Peptide YY Receptor Gene In Primate Species”,The Journal of Biological Chemistry, vol. 271, pp. 27217-27220, 1996.
Michel et al., “XVI. International Union Of Pharmacology Recommendations For The Nomenclature Of Neuropeptide Y, Peptide YY, And Pancreatic Polypeptide Receptors”,Pharmacological Reviews, vol. 50, pp. 143-150, 1998.
Wraith et al., “Evolution Of The Neuropeptide Y Receptor Family: Gene And Chromosome Duplications Deduced From The Cloning And Mapping Of The Five Receptor Subtype Genes In Pig”,Genome Research, vol. 10, pp. 302-310, 2000.
Ma et al., “Variations In Peptide YYand Y2 Receptor Genes Are Associated With Severe Obesity In Pima Indian Men”, Diabetes, vol. 54, pp. 1598-1602, 2005.
Database SNP DB (Online); NCBI: Oct. 10, 2003; rs2880416, XP002515186.
Database SP DB (Online); NCBI: Apr. 3, 2004; rs12507396; XP002515187.
Campbell et al., “Genetic Variation Upstream of NPY2R Is Associated With Obesity In Men”, Retrieved from the Internet, URL:http://www.ashg.org/genetics/abstracts/abs04/f2251.htm; XP002515185; Oct. 30, 2004.
Campbell et al., Diabetes, vol. 56, No. 5, pp. 1460-1467, May 2007.
Database SNP DB [Online] NCBI; Oct. 10, 2003, “rs2342676” retrieved from www.NCBI.NLM.NIH.GOV Database accession No. rs2342676.
Database SNP DB [Online] NCBI; Apr. 3, 2004, “rs12649641” retrieved from www.NCBI.NLM.NIH.GOV Database accession No. rs12649641.
Database SNP DB [Online] NCBI; Apr. 3, 2004, “rs11099992” retrieved from www.NCBI.NLM.NIH.GOV Database accession No. rs11099992.
Database SNP DB [Online] NCBI; Oct. 10, 2003, “rs6857530” retrieved from www.NCBI.NLM.NIH.GOv Database accession No. rs6857530.
Ardlie Kristin
Campbell Catarina deHaseth
Hirschhorn Joel
Children's Medical Center Corporation
Engellenner Thomas J.
Goldberg Jeanine A
Nutter & McClennen & Fish LLP
Seracare Life Sciences, Inc.
LandOfFree
Compositions and methods for obesity screening using... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for obesity screening using..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for obesity screening using... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4223987